Pinetree Therapeutics
PrivateLast Round
Series B
Oct 28, 2025
Est. Valuation
$135M
Total Funding Raised
$87.5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Pinetree Therapeutics is a biotechnology company developing transformative therapies through targeted protein degradation for oncology and other diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pinetree Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Pinetree Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Oct 28, 2025 | ||||
| Series A Extension | Jul 30, 2024 | ||||
| Series A | Jun 7, 2022 |
Pinetree Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| InterVest | Series A |
| SV Investment | Series B |
| DSC Investment | Series B, Series A, Series A Extension |
| Smilegate Investment | Series B |
| STIC Investments | Series A Extension |
| Korea Investment Partners | Series B |
| S&S Investment | Series B, Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 17, 2026
Monthly visitors increased 49% MoM.
- Oct 28, 2025
$47M round led by Atinum Investment and DSC Investment.
Pinetree Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Pinetree Therapeutics's valuation, stock price, and market status.